Literature DB >> 17536161

Smokable ("ice", "crystal meth") and non smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK.

Fabrizio Schifano1, John M Corkery, Giulio Cuffolo.   

Abstract

"Ice", "crystal meth", is the smokable form of methamphetamine hydrochloride. This paper will comment on the pharmacological, epidemiological, clinical and social issues related to smoking the drug as opposed to either its injection or ingestion. Furthermore, some data related to amphetamines/methamphetamines consumption, request for treatment, seizures, related offences and deaths in the UK (1990-2002) will be offered here. Peak rates, for most indicators, were reached at the end of the '90s, to fall down in the following years. The only indicator which seemed not to show any declining rates is number of deaths, but this may be related to a more general increase in stimulant death rates recently observed in the UK. It is argued that methamphetamines, and particularly "crystal meth", could reach the same prevalence levels of use in the UK as it is already in the US but recent reclassification of the drug to Class A in the UK could help to better control this emerging issue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536161

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  12 in total

1.  The impact of the new scene drug "crystal meth" on oral health: a case-control study.

Authors:  Niklas Rommel; Nils H Rohleder; Stefan Wagenpfeil; Roland Härtel-Petri; Frederic Jacob; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  Clin Oral Investig       Date:  2015-07-15       Impact factor: 3.573

2.  A method to quantify illicit intake of drugs from urine: methamphetamine.

Authors:  Linghui Li; Gantt P Galloway; Davide Verotta; E Thomas Everhart; Matthew J Baggott; Jeremy R Coyle; Juan C Lopez; John Mendelson
Journal:  J Pharmacol Exp Ther       Date:  2011-03-30       Impact factor: 4.030

3.  Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose.

Authors:  Linghui Li; Juan Carlos Lopez; Gantt P Galloway; Matthew J Baggott; Tom Everhart; John Mendelson
Journal:  Ther Drug Monit       Date:  2010-08       Impact factor: 3.681

Review 4.  Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy.

Authors:  Daniel Ciccarone
Journal:  Prim Care       Date:  2011-01-11       Impact factor: 2.907

5.  Administration of high dose of methamphetamine has detrimental effects on sperm parameters and DNA integrity in mice.

Authors:  Mojdeh Sabour; Arezoo Khoradmehr; Seyyed Mehdi Kalantar; Amir Hossein Danafar; Marjan Omidi; Iman Halvaei; Ali Nabi; Saeed Ghasemi-Esmailabad; Ali Reza Talebi
Journal:  Int J Reprod Biomed       Date:  2017-03

Review 6.  The neurobiological mechanisms of physical exercise in methamphetamine addiction.

Authors:  António Pedro Delgado Morais; Inês Roque Pita; Carlos Alberto Fontes-Ribeiro; Frederico Costa Pereira
Journal:  CNS Neurosci Ther       Date:  2017-12-20       Impact factor: 5.243

7.  A qualitative study of methamphetamine initiation in Cape Town, South Africa.

Authors:  Andréa L Hobkirk; Melissa H Watt; Bronwyn Myers; Donald Skinner; Christina S Meade
Journal:  Int J Drug Policy       Date:  2015-10-28

Review 8.  Pharmacologic mechanisms of crystal meth.

Authors:  Stephen J Kish
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

9.  Treatment of Methamphetamine Dependence with Electroconvulsive Therapy (ECT) in Iran: A Critical Note.

Authors:  Babak Roshanaei-Moghaddam; Michael C Pauly
Journal:  Iran J Psychiatry       Date:  2014-07

Review 10.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.